| Year |
Citation |
Score |
| 2023 |
Holen B, Kutrolli G, Shadrin AA, Icick R, Hindley G, Rødevand L, O'Connell KS, Frei O, Parker N, Tesfaye M, Deak JD, Jahołkowski P, Dale AM, Djurovic S, Andreassen OA, et al. Genome-wide analyses reveal shared genetic architecture and novel risk loci between opioid use disorder and general cognitive ability. Drug and Alcohol Dependence. 256: 111058. PMID 38244365 DOI: 10.1016/j.drugalcdep.2023.111058 |
0.556 |
|
| 2023 |
Icick R, Shadrin A, Holen B, Karadag N, Parker N, O'Connell K, Frei O, Bahrami S, Høegh M, Lagerberg T, Cheng W, Seibert T, Djurovic S, Dale A, Zhou H, et al. Identification of Novel Loci and Cross-Disorder Pleiotropy Through Multi-Ancestry Genome-Wide Analysis of Alcohol Use Disorder in Over One Million Individuals. Research Square. PMID 38196616 DOI: 10.21203/rs.3.rs-3755915/v1 |
0.708 |
|
| 2023 |
Holen B, Shadrin AA, Icick R, Filiz TT, Hindley G, Rødevand L, O'Connell KS, Hagen E, Frei O, Bahrami S, Cheng W, Parker N, Tesfaye M, Jahołkowski P, Karadag N, et al. Genome-wide analyses reveal novel opioid use disorder loci and genetic overlap with schizophrenia, bipolar disorder, and major depression. Addiction Biology. 28: e13282. PMID 37252880 DOI: 10.1111/adb.13282 |
0.723 |
|
| 2023 |
Cheng W, Parker N, Karadag N, Koch E, Hindley G, Icick R, Shadrin A, O'Connell KS, Bjella T, Bahrami S, Rahman Z, Tesfaye M, Jaholkowski P, Rødevand L, Holen B, et al. The relationship between cannabis use, schizophrenia, and bipolar disorder: a genetically informed study. The Lancet. Psychiatry. 10: 441-451. PMID 37208114 DOI: 10.1016/S2215-0366(23)00143-8 |
0.708 |
|
| 2023 |
Flaudias V, Samalin L, Godin O, Gard S, Brousse G, Loftus J, Aubin V, Belzeaux R, Dubertret C, Le Strat Y, Mazer N, de Prémorel A, Roux P, Polosan M, Schwitzer T, ... ... Icick R, et al. Crossed clinical features between eating disorders and types of bipolar disorder: Results from the FondaMental Advanced Centers of Expertise - Bipolar Disorder cohort. Journal of Affective Disorders. PMID 37178826 DOI: 10.1016/j.jad.2023.05.017 |
0.457 |
|
| 2022 |
Brynte C, Aeschlimann M, Barta C, Begeman AHA, Bäcker A, Crunelle CL, Daigre C, De Fuentes-Merillas L, Demetrovics Z, Dom G, López LG, Icick R, Johnson B, Joostens P, Kapitány-Fövény M, et al. The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study. Bmc Psychiatry. 22: 625. PMID 36151539 DOI: 10.1186/s12888-022-04259-6 |
0.336 |
|
| 2022 |
Hindley G, Frei O, Shadrin AA, Cheng W, O'Connell KS, Icick R, Parker N, Bahrami S, Karadag N, Roelfs D, Holen B, Lin A, Fan CC, Djurovic S, Dale AM, et al. Charting the Landscape of Genetic Overlap Between Mental Disorders and Related Traits Beyond Genetic Correlation. The American Journal of Psychiatry. appiajp21101051. PMID 36069018 DOI: 10.1176/appi.ajp.21101051 |
0.716 |
|
| 2022 |
Icick R, Shadrin A, Holen B, Karadag N, Lin A, Hindley G, O'Connell K, Frei O, Bahrami S, Høegh MC, Cheng W, Fan CC, Djurovic S, Dale AM, Lagerberg TV, et al. Genetic overlap between mood instability and alcohol-related phenotypes suggests shared biological underpinnings. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 35953530 DOI: 10.1038/s41386-022-01401-6 |
0.703 |
|
| 2022 |
Bjella TD, Collier Høegh M, Holmstul Olsen S, Aminoff SR, Barrett E, Ueland T, Icick R, Andreassen OA, Nerhus M, Myhre Ihler H, Hagen M, Busch-Christensen C, Melle I, Lagerberg TV. Developing "MinDag" - an app to capture symptom variation and illness mechanisms in bipolar disorder. Frontiers in Medical Technology. 4: 910533. PMID 35935144 DOI: 10.3389/fmedt.2022.910533 |
0.39 |
|
| 2022 |
Therribout N, Karsinti E, Morel A, Dereux A, Vorspan F, Romo L, Icick R. Feasibility of an Extensive Strategy for Adult Diagnosis of Attention Deficit Hyperactivity Disorder Among Patients Suffering From Substance Use Disorders. Frontiers in Psychiatry. 13: 803227. PMID 35836660 DOI: 10.3389/fpsyt.2022.803227 |
0.304 |
|
| 2022 |
Icick R, Melle I, Etain B, Høegh MC, Gard S, Aminoff SR, Leboyer M, Andreassen OA, Belzeaux R, Henry C, Bjella TD, Kahn JP, Steen NE, Bellivier F, Lagerberg TV. Preventive Medication Patterns in Bipolar Disorder and Their Relationship With Comorbid Substance Use Disorders in a Cross-National Observational Study. Frontiers in Psychiatry. 13: 813256. PMID 35592382 DOI: 10.3389/fpsyt.2022.813256 |
0.458 |
|
| 2021 |
Lagerberg TV, Icick R, Aminoff SR, Nerhus M, Barrett EA, Bjella TD, Olsen SH, Høegh MC, Melle I. Substance Misuse Trajectories and Risk of Relapse in the Early Course of Bipolar Disorder. Frontiers in Psychiatry. 12: 656912. PMID 34017275 DOI: 10.3389/fpsyt.2021.656912 |
0.434 |
|
| 2021 |
Icick R, Gard S, M'Bailara K, Biseul I, Samalin L, Brousse G, Flaudias V, Llorca PM, Loftus J, Cussac I, Aubin V, Schwan R, Roux P, Polosan M, Courtet P, et al. The course of bipolar disorder as a function of the presence and sequence of onset of comorbid alcohol use disorders in outpatients attending the Fondamental Advanced Centres of Expertise. Journal of Affective Disorders. 287: 196-203. PMID 33799038 DOI: 10.1016/j.jad.2021.03.041 |
0.513 |
|
| 2021 |
Icick R, Bloch V, Prince N, Karsinti E, Lépine JP, Laplanche JL, Mouly S, Marie-Claire C, Brousse G, Bellivier F, Vorspan F. Clustering suicidal phenotypes and genetic associations with brain-derived neurotrophic factor in patients with substance use disorders. Translational Psychiatry. 11: 72. PMID 33479229 DOI: 10.1038/s41398-021-01200-5 |
0.452 |
|
| 2020 |
Vorspan F, de Witt P, Zerdazi EH, Karsinti E, Ksouda K, Icick R, Bellivier F, Marie N, Brousse G, Bloch V. Chronic exposure to cocaine is associated with persistent behavioral disturbances. A cross-sectional dimensional study in outpatients with multiple substance use disorders. Psychopharmacology. PMID 32748030 DOI: 10.1007/s00213-020-05620-x |
0.33 |
|
| 2020 |
Icick R, Forget B, Cloëz-Tayarani I, Pons S, Maskos U, Besson M. Genetic susceptibility to nicotine addiction: Advances and shortcomings in our understanding of the CHRNA5/A3/B4 gene cluster contribution. Neuropharmacology. 177: 108234. PMID 32738310 DOI: 10.1016/j.neuropharm.2020.108234 |
0.337 |
|
| 2020 |
Icick R, Moggi F, Slobodin O, Dom G, Mathys F, van den Brink W, Levin FR, Blankers M, Kaye S, Demetrovics Z, van den Glind G, Velez-Pastrana MC, Schellekens ASA. Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders. European Addiction Research. 1-10. PMID 32570249 DOI: 10.1159/000508546 |
0.376 |
|
| 2016 |
Lagerberg TV, Aminoff SR, Aas M, Bjella T, Henry C, Leboyer M, Pedersen G, Bellivier F, Icick R, Andreassen OA, Etain B, Melle I. Alcohol use disorders are associated with increased affective lability in bipolar disorder. Journal of Affective Disorders. 208: 316-324. PMID 27810713 DOI: 10.1016/j.jad.2016.09.062 |
0.499 |
|
| 2016 |
Biseul I, Icick R, Seguin P, Bellivier F, Scott J. Feasibility and Acceptability of the 'HABIT' Group Programme for Comorbid Bipolar and Alcohol and Substance use Disorders. Clinical Psychology & Psychotherapy. PMID 27761983 DOI: 10.1002/cpp.2053 |
0.419 |
|
| 2016 |
Karsinti E, Fortias M, Dupuy G, Ksouda K, Laqueille X, Simonpoli AM, Touzeau D, Avril E, Orizet C, Belforte B, Coeuru P, Polomeni P, Icick R, Jarroir M, Bloch V, et al. Anxiety disorders are associated with early onset of heroin use and rapid transition to dependence in methadone maintained patients. Psychiatry Research. 245: 423-426. PMID 27620325 DOI: 10.1016/j.psychres.2016.04.064 |
0.377 |
|
| 2015 |
Icick R, Peoc'h K, Karsinti E, Ksouda K, Hajj A, Bloch V, Prince N, Mouly S, Bellivier F, Lépine JP, Laplanche JL, Vorspan F. A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 24: 613-20. PMID 26331953 DOI: 10.1111/ajad.12273 |
0.387 |
|
| Show low-probability matches. |